Figure 2. Efficacy of treatment scheme A, cisplatinum (CDDP), on breast osteosarcoma in a patient-derived orthotopic nude-mouse xenograft model. A: Tumor volume at the indicated times relative to that at the start of treatment. B: Mouse body weight at day 15 relative to that at day 1 of treatment. Data are the mean±standard error. Significantly different at p<0.05 from: *control; #3 mg/kg CDDP.
